When used to evaluate tumor initiation of common breast carcinoma cell lines, the percentage of CD44+/CD24- did not correlate to tumorigenicity [35], it does, however, correlate strongly with rare basal and mesenchymal phenotype [39]. This evidence concerns the gene CD24 and breast carcinoma.